<?xml version="1.0" encoding="UTF-8"?>
<urlset
      xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
            http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<!-- created with Free Online Sitemap Generator www.xml-sitemaps.com -->


<url>
  <loc>https://gritstoneoncology.com/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>1.00</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/about/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/news/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/contact/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/our-pipeline/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-to-present-first-data-bridging-tumor-antigen-identification-and-potent-immunotherapy-delivery-in-primates-at-2018-aacr-annual-meeting/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-appoints-jayant-aphale-ph-d-as-executive-vice-president-of-technical-operations/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-appoints-jean-marc-bellemin-as-chief-financial-officer/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-opens-new-state-of-the-art-personalized-cancer-immunotherapy-manufacturing-facility/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-and-arbutus-biopharma-announce-lnp-technology-licensing-agreement-to-develop-novel-rna-based-personalized-neoantigen-immunotherapies-for-cancer-patients/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-secures-92-7-million-in-series-b-financing/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-expands-scientific-advisory-board-with-appointment-of-immuno-oncology-experts-james-l-gulley-and-alessandro-sette/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-appoints-raphael-f-rousseau-m-d-ph-d-as-chief-medical-officer/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/first-public-data-presented-from-gritstone-oncologys-tumor-antigen-identification-platform-for-personalized-cancer-immunotherapy/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/gritstone-oncology-to-present-at-cowen-and-companys-37th-annual-health-care-conference/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>
<url>
  <loc>https://gritstoneoncology.com/content/immune-design-and-gritstone-oncology-announce-clinical-collaboration-for-neoantigen-cancer-immunotherapy/</loc>
  <lastmod>2018-09-04T19:05:23+00:00</lastmod>
  <priority>0.64</priority>
</url>


</urlset>